Blue Owl tipped UK mortgage lender Century into insolvency- FT

Blue Owl Capital has seen its shares slump ~40% in 2026 after halting redemptions at a flagship fund and being linked to triggering Century Capital’s collapse by uncovering financial reporting irregularities that led to administration. Century’s failure preceded insolvency of larger peer Market Financial Solutions amid fraud allegations, raising contagion risks across private credit and UK mortgage lending; monitor redemption activity and private-credit exposures closely.

Analysis

A liquidity shock at a major private-credit platform propagates primarily through contractual funding lines and NAV-linked redemptions rather than direct trading losses; expect the first visible effects within days to weeks as counterparties tighten terms and warehouse lines are drawn or withdrawn. That squeeze forces originators and smaller non-bank lenders to either hoard cash or sell assets into an illiquid market, producing a 10–30% realized impairment on recently-underwritten private loans versus model marks over 3–9 months.

Over 6–18 months the sector bifurcates: well-capitalized balance-sheet buyers and opportunistic credit managers capture dislocated yields and market share, while mid-sized specialists without sticky long-term capital face either consolidation or fire-sale exits. For public markets this implies greater dispersion across asset managers (fee-bearing assets decline at weaker firms) and a higher probability of regulatory scrutiny that raises compliance costs and slows fundraising — a multi-quarter drag on organic growth for exposed managers.

Near-term tail risks (days–months) are liquidity runs into redemption gates, margining blows to warehouses and accelerated covenant tests; medium-term catalysts (3–12 months) are forensic audits and litigation outcomes that re-price private-credit NAVs; long-term shifts (1–3 years) include structural rerating of non-bank credit and potential policy responses that favor regulated deposit-taking lenders. A reversal would require a credible backstop (capital injections or explicit liquidity backstops) or rapid, transparent price discovery that stops forced selling — monitor fund-level cash-flow and facility utilization as the earliest leading indicators.

Key Decisions for Investors

• Short OWL equity via Jan-2027 puts (size 1–2% NAV). Rationale: asymmetric downside from redemption/regulatory shocks; target 40–60% implied downside within 6–12 months. Risk: firm-level recapitalization or asset sale can cap losses — premium is the max loss.
• Pair trade: short small/mid-cap non-bank lenders (select names with high leverage to private-credit origination) and long JPM (or BAC) 6–12 month calls. Rationale: capture market-share shift to deposit-funded banks; expected relative outperformance if non-bank funding tightens. Risk/reward: aim for 2:1 skew — 20% fall in lenders vs 5–10% move in banks.
• Long selective distressed-capital managers (e.g., ARES or OAK/alternative credit allocators) via 9–18 month call spreads or buy-and-hold equity (size 1–3% NAV). Rationale: these firms can deploy dry powder to buy loans at 15–30% discounts and earn elevated fee income; potential 25–40% upside if repricing continues. Risk: execution risk if fundraising stalls or they share exposures.
• Hedge credit exposure: buy 3–12 month IG CDS protection or put on an index of BBB corporates (or reduce net credit beta). Rationale: increased odds of mark-to-market losses spilling into public credit; protection caps portfolio drawdowns during discovery phase. Cost: premium paid; benefits if spread widening >50–100bps.